ET Now on MSN
Aurobindo Pharma’s arm CuraTeQ Biologics receives Health Canada NOC for cancer drug biosimilar Dyrupeg
Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received Health Canada’s compliance notice for its biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback